跳至主要内容
临床试验/NCT02748668
NCT02748668终止不适用

Extracorporeal Membrane Oxygenation: Blood Cells

Spectrum Health Hospitals1 个研究点 分布在 1 个国家目标入组 371 人开始时间: 2015年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
371
试验地点
1
主要终点
All cause mortality

研究概览

简要总结

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Greater than or equal to 18 years of age
  • Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.

排除标准

  • Subject is less than 18 years of age
  • Known prisoner
  • Control Subjects:
  • Inclusion Criteria
  • Greater than 18 years of age
  • Without any known cardiovascular, lung, or autoimmune disease.
  • Exclusion Criteria:
  • Less than or equal to 18 years of age
  • Known cardiovascular, lung, or autoimmune disease

结局指标

主要结局

All cause mortality

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Renzo Loyaga Rendon

Medical Director of Cardiovascular Research

Spectrum Health Hospitals

研究点 (1)

Loading locations...

相似试验